These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

489 related articles for article (PubMed ID: 28183610)

  • 1. Preparation of efficient quercetin delivery system on Zn-modified mesoporous SBA-15 silica carrier.
    Trendafilova I; Szegedi A; Mihály J; Momekov G; Lihareva N; Popova M
    Mater Sci Eng C Mater Biol Appl; 2017 Apr; 73():285-292. PubMed ID: 28183610
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ketoprofen mesoporous silica nanoparticles SBA-15 hard gelatin capsules: preparation and in vitro/in vivo characterization.
    Abd-Elrahman AA; El Nabarawi MA; Hassan DH; Taha AA
    Drug Deliv; 2016 Nov; 23(9):3387-3398. PubMed ID: 27167529
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mesoporous silica as topical nanocarriers for quercetin: characterization and in vitro studies.
    Sapino S; Ugazio E; Gastaldi L; Miletto I; Berlier G; Zonari D; Oliaro-Bosso S
    Eur J Pharm Biopharm; 2015 Jan; 89():116-25. PubMed ID: 25478737
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optimization of tetracycline hydrochloride adsorption on amino modified SBA-15 using response surface methodology.
    Hashemikia S; Hemmatinejad N; Ahmadi E; Montazer M
    J Colloid Interface Sci; 2015 Apr; 443():105-14. PubMed ID: 25540827
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exploitation of 3D face-centered cubic mesoporous silica as a carrier for a poorly water soluble drug: influence of pore size on release rate.
    Zhu W; Wan L; Zhang C; Gao Y; Zheng X; Jiang T; Wang S
    Mater Sci Eng C Mater Biol Appl; 2014 Jan; 34():78-85. PubMed ID: 24268236
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ordered mesoporous silica modified with lanthanum for ibuprofen loading and release behaviour.
    Goscianska J; Olejnik A; Nowak I; Marciniak M; Pietrzak R
    Eur J Pharm Biopharm; 2015 Aug; 94():550-8. PubMed ID: 26170160
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modifying release of poorly soluble active pharmaceutical ingredients with the amine functionalized SBA-16 type mesoporous materials.
    Jadach B; Feliczak-Guzik A; Nowak I; Milanowski B; Piotrowska-Kempisty H; Murias M; Lulek J
    J Biomater Appl; 2019 Apr; 33(9):1214-1231. PubMed ID: 30791849
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Luminescence functionalization of SBA-15 by YVO4:Eu3+ as a novel drug delivery system.
    Yang P; Huang S; Kong D; Lin J; Fu H
    Inorg Chem; 2007 Apr; 46(8):3203-11. PubMed ID: 17371013
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Galactosylated Chitosan-Functionalized Mesoporous Silica Nanoparticle Loading by Calcium Leucovorin for Colon Cancer Cell-Targeted Drug Delivery.
    Liu W; Wang F; Zhu Y; Li X; Liu X; Pang J; Pan W
    Molecules; 2018 Nov; 23(12):. PubMed ID: 30486276
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modification of mesoporous silica with molecular imprinting technology: A facile strategy for achieving rapid and specific adsorption.
    Xu Z; Deng P; Li J; Tang S; Cui Y
    Mater Sci Eng C Mater Biol Appl; 2019 Jan; 94():684-693. PubMed ID: 30423755
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Carboxylic modified spherical mesoporous silicas аs drug delivery carriers.
    Popova MD; Szegedi Á; Kolev IN; Mihály J; Tzankov BS; Momekov GT; Lambov NG; Yoncheva KP
    Int J Pharm; 2012 Oct; 436(1-2):778-85. PubMed ID: 22884833
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and surface modification of mesoporous silica nanoparticles and its application as carriers for sustained drug delivery.
    Ahmadi E; Dehghannejad N; Hashemikia S; Ghasemnejad M; Tabebordbar H
    Drug Deliv; 2014 May; 21(3):164-72. PubMed ID: 24116869
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nanostructured SBA-15 host applied in ketorolac tromethamine release system.
    Cussa J; Juárez JM; Gómez Costa MB; Anunziata OA
    J Mater Sci Mater Med; 2017 Aug; 28(8):113. PubMed ID: 28625001
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A pH dependent delivery of mesalazine from polymer coated and drug-loaded SBA-16 systems.
    Trendafilova I; Szegedi Á; Yoncheva K; Shestakova P; Mihály J; Ristić A; Konstantinov S; Popova M
    Eur J Pharm Sci; 2016 Jan; 81():75-81. PubMed ID: 26453768
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Verapamil delivery systems on the basis of mesoporous ZSM-5/KIT-6 and ZSM-5/SBA-15 polymer nanocomposites as a potential tool to overcome MDR in cancer cells.
    Popova M; Mihaylova R; Momekov G; Momekova D; Lazarova H; Trendafilova I; Mitova V; Koseva N; Mihályi J; Shestakova P; St Petkov P; Aleksandrov HA; Vayssilov GN; Konstantinov S; Szegedi Á
    Eur J Pharm Biopharm; 2019 Sep; 142():460-472. PubMed ID: 31336182
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preparation, characterization and application of p-tert-butyl-calix[4]arene-SBA-15 mesoporous silica molecular sieves.
    Huang H; Zhao C; Ji Y; Nie R; Zhou P; Zhang H
    J Hazard Mater; 2010 Jun; 178(1-3):680-5. PubMed ID: 20185235
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hollow mesoporous silica as a high drug loading carrier for regulation insoluble drug release.
    Geng H; Zhao Y; Liu J; Cui Y; Wang Y; Zhao Q; Wang S
    Int J Pharm; 2016 Aug; 510(1):184-94. PubMed ID: 27262268
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The investigation of MCM-48-type and MCM-41-type mesoporous silica as oral solid dispersion carriers for water insoluble cilostazol.
    Wang Y; Sun L; Jiang T; Zhang J; Zhang C; Sun C; Deng Y; Sun J; Wang S
    Drug Dev Ind Pharm; 2014 Jun; 40(6):819-28. PubMed ID: 23594300
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modified SBA-15 mesoporous silica for heavy metal ions remediation.
    Mureseanu M; Reiss A; Stefanescu I; David E; Parvulescu V; Renard G; Hulea V
    Chemosphere; 2008 Nov; 73(9):1499-504. PubMed ID: 18760443
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dissolution enhancement of a model poorly water-soluble drug, atorvastatin, with ordered mesoporous silica: comparison of MSF with SBA-15 as drug carriers.
    Maleki A; Hamidi M
    Expert Opin Drug Deliv; 2016; 13(2):171-81. PubMed ID: 26636904
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.